NCT00001398View on ClinicalTrials.gov

Stem Cell Factor Medication for Aplastic Anemia

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 1993

Study Completion Date

June 30, 2002

Conditions
Aplastic AnemiaPancytopenia
Interventions
DRUG

Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001398 - Stem Cell Factor Medication for Aplastic Anemia | Biotech Hunter | Biotech Hunter